Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Meta-analysis of MR imaging in the diagnosis of breast lesions.

Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH.

Radiology. 2008 Jan;246(1):116-24. Epub 2007 Nov 16.

PMID:
18024435
2.

Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.

Chen X, Li WL, Zhang YL, Wu Q, Guo YM, Bai ZL.

BMC Cancer. 2010 Dec 29;10:693. doi: 10.1186/1471-2407-10-693.

3.
4.

Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis.

Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP.

Acad Radiol. 1999 Jul;6(7):387-97.

PMID:
10410164
5.
6.

Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.

Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O.

Radiology. 2000 Aug;216(2):545-53.

PMID:
10924584
7.

Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.

Imamura T, Isomoto I, Sueyoshi E, Yano H, Uga T, Abe K, Hayashi T, Honda S, Yamaguchi T, Uetani M.

Magn Reson Med Sci. 2010;9(4):217-25.

8.

Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.

Shimauchi A, Giger ML, Bhooshan N, Lan L, Pesce LL, Lee JK, Abe H, Newstead GM.

Radiology. 2011 Mar;258(3):696-704. doi: 10.1148/radiol.10100409. Epub 2011 Jan 6.

PMID:
21212365
9.

Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.

Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J.

Radiology. 2006 Jun;239(3):666-76. Epub 2006 Mar 20.

PMID:
16549623
10.

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.

J Magn Reson Imaging. 2008 Nov;28(5):1157-65. doi: 10.1002/jmri.21570.

PMID:
18972357
11.
12.

Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.

Nunes LW, Schnall MD, Siegelman ES, Langlotz CP, Orel SG, Sullivan D, Muenz LA, Reynolds CA, Torosian MH.

AJR Am J Roentgenol. 1997 Aug;169(2):409-15.

PMID:
9242744
13.

Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.

Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA.

Radiology. 2006 Jan;238(1):42-53.

PMID:
16373758
14.

Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.

Choi N, Han BK, Choe YH, Kim HS.

J Comput Assist Tomogr. 2005 Nov-Dec;29(6):834-41.

PMID:
16272861
15.

Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T.

Teifke A, Hlawatsch A, Beier T, Werner Vomweg T, Schadmand S, Schmidt M, Lehr HA, Thelen M.

Radiology. 2002 Sep;224(3):881-8.

PMID:
12202728
16.

Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.

Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.

Radiology. 2010 Dec;257(3):653-61. doi: 10.1148/radiol.10100732. Epub 2010 Sep 30.

PMID:
20884914
17.

Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.

Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.

Radiology. 2007 Jun;243(3):670-80. Epub 2007 Apr 19.

PMID:
17446524
18.

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?

Wu LM, Hu JN, Gu HY, Hua J, Chen J, Xu JR.

Breast Cancer Res Treat. 2012 Aug;135(1):17-28. doi: 10.1007/s10549-012-2033-5. Epub 2012 Apr 4. Review.

PMID:
22476850
19.

Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H.

Eur J Radiol. 2010 Jul;75(1):e126-32. doi: 10.1016/j.ejrad.2009.09.013. Epub 2009 Sep 30.

PMID:
19796900
20.

A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.

Pinker K, Grabner G, Bogner W, Gruber S, Szomolanyi P, Trattnig S, Heinz-Peer G, Weber M, Fitzal F, Pluschnig U, Rudas M, Helbich T.

Invest Radiol. 2009 Sep;44(9):553-8. doi: 10.1097/RLI.0b013e3181b4c127.

PMID:
19652611

Supplemental Content

Support Center